Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Suicide, COVID-19, and Ketamine PDF full book. Access full book title Suicide, COVID-19, and Ketamine by Johnathan Edwards. Download full books in PDF and EPUB format.
Author: Johnathan Edwards Publisher: ISBN: 9780978709440 Category : Languages : en Pages : 300
Book Description
Why a book about suicide, COVID-19, and Ketamine? These delicate topics are more inter-related than you might think. The World Health Organization (WHO) estimates that each year 800,000 people die from suicide. But have you wondered about the long-term unintended consequences of COVID-19? The deluge of mental-health problems like depression, suicide, and drug overdoses resulting from the pandemic. Depression, suicide and drug overdoses have been a problem since long before the pandemic. But COVID-19 has made the situation worse: it is more of a crisis than a pandemic. Lockdowns have fueled a litany of tragedies: suicides, drug overdoses, heightened crime, starvation, financial ruin, and much more. Adolescent and adult mental illness have skyrocketed during the crisis, and the tsunami of post-traumatic stress, depression, and suicides will follow. The mental-health consequences will persist long after the COVID-19 pandemic ends. Because of the lockdowns, we expect millions of people will die of hunger and postponed medical treatments, a potential outcome that, unfortunately, has developed less notice. The result is a "perfect storm" of suicides and drug overdose deaths. Mental-health practitioners are employing everything, including telemedicine, to help people battle this threat. Suicide is subtle, and the decision to take your own life is often impulsive. The treatment of suicide and depression is complex, with current medications taking weeks or months to work. When a loved one commits suicide, they leave many unanswered questions. Constant thoughts of "what" and "why," permeate the minds of those left behind. We do not have many effective treatments for suicide. But there is one drug that can often stop suicide in its tracks: ketamine. Few are aware that this decades-old anesthetic and party drug might save your loved one's or even your life. Our goal is to convince you ketamine is a legitimate path to treat mental disorders. Simply said, ketamine works. If your loved one was suicidal, would you suggest trying ketamine? Or use it yourself?
Author: Johnathan Edwards Publisher: ISBN: 9780978709440 Category : Languages : en Pages : 300
Book Description
Why a book about suicide, COVID-19, and Ketamine? These delicate topics are more inter-related than you might think. The World Health Organization (WHO) estimates that each year 800,000 people die from suicide. But have you wondered about the long-term unintended consequences of COVID-19? The deluge of mental-health problems like depression, suicide, and drug overdoses resulting from the pandemic. Depression, suicide and drug overdoses have been a problem since long before the pandemic. But COVID-19 has made the situation worse: it is more of a crisis than a pandemic. Lockdowns have fueled a litany of tragedies: suicides, drug overdoses, heightened crime, starvation, financial ruin, and much more. Adolescent and adult mental illness have skyrocketed during the crisis, and the tsunami of post-traumatic stress, depression, and suicides will follow. The mental-health consequences will persist long after the COVID-19 pandemic ends. Because of the lockdowns, we expect millions of people will die of hunger and postponed medical treatments, a potential outcome that, unfortunately, has developed less notice. The result is a "perfect storm" of suicides and drug overdose deaths. Mental-health practitioners are employing everything, including telemedicine, to help people battle this threat. Suicide is subtle, and the decision to take your own life is often impulsive. The treatment of suicide and depression is complex, with current medications taking weeks or months to work. When a loved one commits suicide, they leave many unanswered questions. Constant thoughts of "what" and "why," permeate the minds of those left behind. We do not have many effective treatments for suicide. But there is one drug that can often stop suicide in its tracks: ketamine. Few are aware that this decades-old anesthetic and party drug might save your loved one's or even your life. Our goal is to convince you ketamine is a legitimate path to treat mental disorders. Simply said, ketamine works. If your loved one was suicidal, would you suggest trying ketamine? Or use it yourself?
Author: Johnathan Edwards Publisher: Simon and Schuster ISBN: 1510777954 Category : Health & Fitness Languages : en Pages : 286
Book Description
This isn't a new drug, but it's now being used to treat depression with amazing results. What exactly is it? Is it safe? Is it right for you or your loved one? Suicide captures everyone’s attention. Suicide is a tragedy usually preceded by plenty of pain. About 1 million go through with the act each year. Imagine if your loved one is determined to end their life, and you could get them help. After reading Revolutionary Ketamine, you will understand: Suicide’s devastating cost to society and how to prevent it Why children and adolescents are committing suicide How ketamine stops suicide in its tracks Suicide is the stuff of other people’s nightmares until it happens to someone you love. Time simply stops, leaving you wondering what could have been done. Suicidal ideations hijack our brains, telling us to end our lives prematurely. What if we could remove this hijacking device? Ketamine is the one drug we have today that can safely halt suicidal ideations, yet most have never heard of it. To those who say more studies are needed to know if ketamine helps with suicidal ideations and depression, I offer you this admonition before trying the drug. If you are suffering from depression and suicidal ideations, the risk versus reward is clearly in favor of using ketamine now. Don’t wait. Dr. Edwards, the author of Revolutionary Ketamine, is committed to helping those who need never become statistics at all and will equip you with the tools to save your loved one’s life, or possibly your own.
Author: Sanjay J. Mathew Publisher: Springer ISBN: 3319429256 Category : Medical Languages : en Pages : 155
Book Description
This book brings together an international group of clinicians and researchers from a broad swath of inter-related disciplines to offer the most up-to-date information about clinical and preclinical research into ketamine and second-generation “ketamine-like” fast-acting antidepressants. Currently available antidepressant medications act through monoaminergic systems, are ineffective for many individuals suffering from depression, and are associated with a delayed onset of peak efficacy of several months. The unexpected emergence of ketamine, an anesthetic N-methyl-D-aspartate (NMDA) receptor antagonist, as a rapid-acting antidepressant has reinvigorated CNS drug discovery research and catalyzed investigation in patient populations historically ignored in antidepressant drug development programs, particularly treatment-resistant patients and those with suicidality. Recent industry and academic research efforts have coalesced to explore NMDA receptor and glutamatergic molecular targets that lack ketamine’s psychotomimetic side effects and abuse liability but retain its rapid onset of efficacy. However, many fundamental questions remain regarding the neurobiological mechanisms underlying ketamine’s rapid antidepressant effects and the puzzling persistence of benefits observed in some patients following a single dose. This book examines how insights from these studies are forging new conceptual models of the neurobiology of stress-related affective, anxiety, and addictive disorders and the nature of treatment resistance. It also discusses how ketamine’s rapid antidepressant effects provide a scientific platform to facilitate innovation in clinical trial designs pertaining to patient selection, choice of control group, outcome measures, and dose-optimization. This book brings together data and insights from this rapidly expanding and extraordinarily promising field of study. Readers will be able to extract integrated themes and useful insights from the material contained in these diverse chapters and appreciate the paradigm-shifting contributions of ketamine to modern psychiatry and clinical neuroscience research.
Author: Publisher: Academic Press ISBN: 0128201908 Category : Medical Languages : en Pages : 404
Book Description
The Advances in Pharmacology series presents a variety of chapters from the best authors in the field. Includes the authority and expertise of leading contributors in pharmacology Presents the latest release in the Advances in Pharmacology series
Author: Dr. Stephen J. Hyde Publisher: Xlibris Corporation ISBN: 1503509532 Category : Health & Fitness Languages : en Pages : 222
Book Description
Given the unacceptably high rates of suffering, disability and premature death experienced by people with treatment-resistant depression and the surprisingly low rates of problems arising from the use of ketamine to treat the disorder, this is a therapy that all patients and their doctors should be discussing. This book summarises the research that has been carried out into ketamine for the treatment of depression over the past 15 years and, most importantly, describes different ways of using ketamine that are both practical and cost–effective. Currently most ketamine therapy is given intravenously in specialised clinics at considerable expense, but the author has successfully treated patients with low-dose sublingual ketamine and his patients have been able to safely take this at home. Profits from the sales of this book will assist further research into the use of ketamine for the treatment of depression.
Author: Phil Wolfson Publisher: ISBN: 9780998276502 Category : Body, Mind & Spirit Languages : en Pages : 420
Book Description
The Ketamine Papers opens the door to a broad understanding of this medicine's growing use in psychiatry and its decades of history providing transformative personal experiences. Now gaining increasing recognition as a promising approach to the treatment of depression, posttraumatic stress disorder (PTSD), and other psychological conditions, ketamine therapies offer new hope for patients and clinicians alike. With multiple routes of administration and practices ranging from anesthesia to psychotherapy, ketamine medicine is a diverse and rapidly growing field. The Ketamine Papers clarifies the issues and is an inspiring introduction to this powerful tool for healing and transformation--from its early use in the 1960s to its emerging role in the treatment of depression, suicidality, and other conditions. This comprehensive volume is the ideal introduction for patients and clinicians alike, and for anyone interested in the therapeutic and transformative healing power of this revolutionary medicine.
Author: John F. Cryan Publisher: Springer Science & Business Media ISBN: 3642278590 Category : Medical Languages : en Pages : 637
Book Description
This book covers a wide array of topics relevant to behavioral genetics from both a preclinical and clinical standpoint. Indeed in juxtaposing both areas of research the reader will appreciate the true translational nature of the field. Topics covered range from technical advances in genetic analysis in humans and animals to specific descriptions of advances in schizophrenia, attention disorders, depression and anxiety disorders, autism, aggression, neurodegeneration and neurodevelopmental disorders. The importance of gene-environment interactions is emphasised and the role of neuroimaging in unravelling the functional consequences of genetic variability described. This volume will be valued by both the basic scientist and clinician alike who may use it as a detailed reference book. It will also be of use to the novice to the field, to whom it will serve as an in-depth introduction to this exciting area of research.
Author: Keri E. Cannon Publisher: Springer ISBN: 3319099647 Category : Medical Languages : en Pages : 309
Book Description
This book addresses the phenomenology, demographics, and neurobehavioral aspects of suicidal behavior and its risk factors, underscoring common neurobehavioral threads among different approaches which may underlie such extreme behavior. It additionally provides an overview of new approaches, such as imaging techniques to identify at-risk individuals or in response to drug treatment associated with suicidal behavior, neurodevelopmental approaches, genetic and epigenetic linkages to suicidal behavior, animal models of specific risk factors, as well as potential biomarkers being employed to help assess risk.
Author: Michael B. First Publisher: American Psychiatric Pub ISBN: 1585627356 Category : Medical Languages : en Pages : 192
Book Description
In clinical settings clinicians continue to underutilize interviews and rating scales because their benefits are underappreciated and their use is perceived as too costly and time consuming. Augmenting the broad information contained in the APA's Handbook of Psychiatric Measures, this in-depth guide examines the real-world issues involved in implementing measures in actual clinical settings. This book Asserts that the use of structured diagnostic interviews in clinical settings is justified, suggesting that it would be most cost-effective to target research assessment toward those groups most difficult to evaluate and most likely to be misdiagnosed, especially those whose misdiagnosis leads to consumption of a greater-than-expected amount of treatment resources Focuses on the underrecognition and underreporting of diagnostic comorbidity, discussing the daunting practical issues of using comprehensive structured interviews and suggesting instead that a self-administered questionnaire be used to screen for the most common DSM-IV Axis I disorders Considers the use of structured interviews-administered by either lay interviewers or by computer-in the diagnostic assessment of children and adolescents, making a case that using the research model (i.e., reliable measures that can be given to large numbers of subjects) in clinical settings meets the cost-efficiency requirements of understaffed clinical providers Discusses the utility and limitations of research instruments for crucially important clinical purposes-determining suicide risk-and presents the inherent difficulties in predicting risk and explore the underlying clinical risk factors based on their proposed stress-diathesis model Presents the issues and challenges involved in the U.S. Department of Veteran's Affairs (VA) attempt to implement a national program requiring the routine use of the GAF scale. The authors conclude with a discussion of the reasons why the Global Assessment of Functioning (GAF) scale was chosen, software and procedures, methods to ensure system compliance, and the specific measures taken by two VA networks that helped improve its implementation It is a groundbreaking guide that details the pros and cons of using structured interviews and rating scales in clinical settings to ensure reliable and valid assessment of diagnoses, symptoms, and outcomes.
Author: André Carvalho Publisher: Oxford Psychiatry Library ISBN: 0198707991 Category : Medical Languages : en Pages : 175
Book Description
Treatment-resistant major depression and bipolar disorder are highly prevalent and disabling conditions associated with substantial morbidity and mortality. Providing a concise view of the current definitions, assessment and evidence-based management of such disorders, this work reviews novel therapeutic targets, which may enhance the future therapeutic armamentarium of clinicians.
Author: Johnathan Edwards
Author: Johnathan Edwards
Author: Johnathan Edwards
Author: Sanjay J. Mathew
Author: 
Author: Dr. Stephen J. Hyde
Author: Phil Wolfson
Author: John F. Cryan
Author: Keri E. Cannon
Author: Michael B. First
Author: André Carvalho